Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for prevention of chronic postsurgical pain after inguinal hernia repair
NCT06606067Phase 3Active, not recruiting
- Sponsor
- Parc de Salut Mar
- Start
- Sep 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of duloxetine in chronic postsurgical pain (CPSP), sponsored by Parc de Salut Mar. Started Sep 2024; status: active, not recruiting.
02
Drugs
duloxetine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT06606067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06606067.